Suraxavir marboxil

DRUG2 trials

Sponsors

Jiangxi Kerui Pharmaceutical Co., Ltd, Capital Medical University

Conditions

Influenza

Phase 3

A Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Suraxavir Marboxil for Suspension

Not yet recruitingNCT07113392

Jiangxi Kerui Pharmaceutical Co., LtdInfluenza

Start: 2025-08-01End: 2026-08-01Target: 144Updated: 2025-08-08

Suraxavir Marboxil And Oseltamivir for Influenza Prophylaxis Under a Hospital-based Setting

RecruitingNCT07236814

Capital Medical UniversityInfluenza

Start: 2025-11-28End: 2027-03-06Target: 384Updated: 2026-03-23